<code id='627C25510A'></code><style id='627C25510A'></style>
    • <acronym id='627C25510A'></acronym>
      <center id='627C25510A'><center id='627C25510A'><tfoot id='627C25510A'></tfoot></center><abbr id='627C25510A'><dir id='627C25510A'><tfoot id='627C25510A'></tfoot><noframes id='627C25510A'>

    • <optgroup id='627C25510A'><strike id='627C25510A'><sup id='627C25510A'></sup></strike><code id='627C25510A'></code></optgroup>
        1. <b id='627C25510A'><label id='627C25510A'><select id='627C25510A'><dt id='627C25510A'><span id='627C25510A'></span></dt></select></label></b><u id='627C25510A'></u>
          <i id='627C25510A'><strike id='627C25510A'><tt id='627C25510A'><pre id='627C25510A'></pre></tt></strike></i>

          knowledge

          knowledge

          author:comprehensive    Page View:49282

          Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET.

          STAT’s reporters, strung-out from several days of ASCO madness, will take the virtual stage to share convention hall insights, predictions for the months ahead, and of course will take your audience questions live.

          advertisement

          Sponsor Introduction

          • Ashwin Athri, EVP, strategy, innovation, & partnerships, Precision AQ

          Featured Speakers

          • Angus Chen, cancer reporter, STAT
          • Adam Feuerstein, senior writer, biotech, STAT
          • Matthew Herper, senior writer, medicine; editorial director of events, STAT
          • Katherine MacPhail, programmer, editorial events, STAT (moderator)

          Sponsored By

          Wikipedia

          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more
          The cancer stories no one wants to hear
          The cancer stories no one wants to hear

          KARL-JOSEFHILDENBRAND/AFP/GettyImagesDuringthe11monthswhenmyhusband,Ahmad,wasdyingofbladdercancer,fe

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          FDA rejects Alnylam's heart disease treatment over insufficient data

          KristofferTripplaar/SipaUSA/APTheFoodandDrugAdministrationrejectedanAlnylamPharmaceuticals’therapyfo